Medical Polymer Market - Global Forecast To 2030
商品番号 : SMB-56116
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 451 |
| 図表数 | 415 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本市場調査は、様々なセグメントにわたる医療用ポリマー市場を網羅しています。市場規模と成長ポテンシャルを、タイプ、用途、製造技術、地域に基づき、様々なセグメントにわたって推定することを目的としています。また、主要プレーヤーの詳細な競合分析、企業概要、製品および事業内容に関する主要な考察、最近の開発状況、そして医療用ポリマー市場における地位向上のために採用されている主要な成長戦略についても取り上げています。
本レポートは、市場リーダー企業および新規参入企業が、医療用ポリマー市場全体、ならびにそのセグメントおよびサブセグメントの収益数値について、より正確な概算値を共有する上で役立つことが期待されます。本レポートは、ステークホルダーが市場の競争環境を理解し、自社の地位向上のための洞察を獲得し、適切な市場開拓戦略を策定する上で役立つことが期待されます。また、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供することも目的としています。
医療用ポリマー市場は、予測期間中に年平均成長率8.2%で成長し、2025年の447億米ドルから2030年には662億9000万米ドルに達すると予測されています。
医療用ポリマー市場は、ヘルスケア、材料工学、そして患者中心のイノベーションの継続的な進歩により、急速な成長を遂げています。その主な要因として、軽量で耐久性があり、インプラントやカテーテル、診断機器、さらには手術器具といった生体適合性材料を使用する状況に適した材料へのニーズが挙げられます。慢性疾患の増加、人口の高齢化、そして低侵襲手術の必要性により、柔軟性、安全性、そして精度を提供する高度なポリマーが求められています。衛生管理と汚染物質の低減のため、可能な限り使い捨て医療製品の使用が大幅に増加したことで、ポリマー製部品の普及が促進されました。ポリマー科学は、優れた機械的強度、耐久性、抗菌性、そして能動滅菌技術との適合性を備えたポリマーや材料の開発に向けて進歩を続けています。知識と開発の進歩により、形状を保持できるポリマー、つまり生体吸収性ポリマーの飛躍的な進歩がもたらされ、薬物送達デバイスや組織工学の分野での可能性が開かれています。医療グレードの3Dプリントの普及は、カスタム設計のインプラントやデバイスを迅速に開発できるようになり、この分野に革命をもたらしました。持続可能な取り組みへの関心が高まり、リサイクル可能で生分解性のポリマーへの関心が高まっています。
The medical polymer market is projected to reach USD 66.29 billion by 2030 from USD 44.70 billion in 2025, at a CAGR of 8.2% during the forecast period. The medical polymer market is experiencing rapid growth as a result of continual progress in healthcare, materials engineering, and patient-focused innovation. Major factors driving include need for materials that are lightweight, durable, and suitable for use in situations involving biocompatible materials, like implants or catheters, diagnostic equipment, and even surgical instruments. The increased prevalence of chronic diseases, aging population, and the need for minimally invasive procedures is creating preference for advanced polymers that provide flexibility, security, and accuracy. The considerable shift in the use of disposable medical products, where possible, for sanitation and fewer contaminants has contributed to the proliferation of components made from polymers. The science of polymers is advancing to create polymers and materials with superior mechanical strength, durability, antimicrobial properties, and compatibility with active-sterilization techniques. Advances in knowledge and developments have resulted in breakthroughs in polymers that can hold shapes, or bioresorbable, that offer opportunities in the areas of drug delivery devices and tissue engineering. Proliferation of medical-grade 3D printing has revolutionized this area because custom-designed implants and devices can now be developed rapidly. There has increased attention on sustainable practices, leading to interest in recyclable and biodegradable polymers.
“Medical elastomers to account for the second-largest type in the medical polymer market during the forecast period.”
Medical elastomers account for the second-largest type in the medical polymer market based on unique combinations of characteristics, such as flexibility, durability, and biocompatibility, allowing them to be used for hundreds of precise applications for critical healthcare. Many of the devoted elastomer applications are products used to contain fluids or products that need to be manipulated with constant movement, stretching, or compression, like seals, gaskets, tubing, syringes, plungers, and catheter components. Medical elastomer products are best known because of their chemical resistance, resistance to temperature swings, and resistance to sterilization techniques, which enables reliable products in high-stress medical applications. Because silicone elastomers, thermoplastic elastomers (TPE), and rubber materials are often specifically mentioned in literature due to increased comfort above conventional or hard polymers, they are favored for wearable medical devices and skin-contact applications. In addition, the influence of minimization continues to drive performance elastomeric materials, as do the advanced design aspects influencing drug delivery systems, automated enclosed testing systems, and lifestyle diagnostic devices. Furthermore, elastomeric materials are especially amenable to automated manufacturing and/or molding with E-modulus and tensile strength decreases, enabling cost-effective production in considerably large amounts. Combined with supporting and allowing innovation and safety in modern healthcare, these ultimately contribute to the fast-growing and extremely important category of medical elastomers in the medical polymer market.
“Medical disposables to account for the second-largest share of the medical polymer market during the forecast period.”
Medical disposables are the second-largest application in the medical polymer market because of their importance in cleanliness, patient safety, and infection control in healthcare settings. Items such as syringes, gloves, IV bags, tubing and connections, surgical drapes, and masks are designed for single-use to prevent cross-contamination and maintain sterile environments. The emphasis on infection prevention and regulations supporting infection control have increased demand for disposable medical items. Due to their excellent processability, low cost, and compatibility with sterilizing processes, the polymers used in medical disposables are primarily polypropylene, polyethylene, and PVC. The increase in hospital stays, enhanced surgical procedures, and outpatient care, especially in emerging regions, are driving demand for good quality disposables. Convenience of ready-to-use pre-sterilized items can add efficiency in busy medical settings. As healthcare continues to focus on safety, cost-effective practices, and efficiencies, polymer medical disposables will be an important future growth area going forward.
“Injection molding is projected to be the second-largest manufacturing technology in the medical polymer market during the forecast period.”
Injection molding is the second-largest manufacturing technology in the medical polymer space because it can produce highly precise and complex components at scale with good reliability and efficiency. Injection molding is used to produce a wide variety of medical products, for example, housing for diagnostic equipment, surgical instrument handles, syringes, connectors, components of implantable devices, and so forth. Injection molding is compatible with many medical-grade polymers, for example, it can be made from polycarbonate, polypropylene, and ABS. With injection molding, the manufacture of components that must have strength, biocompatibility, chemical resistance, and washability is possible. Injection molding can be made to tight tolerances with complex geometries; all of which are relevant in meeting the safety and performance requirements of the medical device industry. Injection molding is also compatible with automation and is conducive to produce items in large volumes while being cost-effective along with high quality output. Recent advancements in multi-shot and micro fabrication further enhances the application range as well. With all of these advantages it is easy to see how injection molding plays a critical role in the medical polymer market which supports product innovations and continues to aid the demand for sophisticated and reliable medical products.
“North America is projected to be the second-fastest growing region in the medical polymer market during the forecast period.”
North America is the second-fastest growing region in the medical polymer market, due largely to strong healthcare dynamics, and innovated demand. Per capita healthcare expenses are rising, initiated by expanding insurance coverage in the US and strong public and private healthcare investments in Canada. The medical devices, packaging, and wound care categories are projected to account for greater growth in North America than any other region as healthcare advances. However, the US has one of the most innovative healthcare environments in the world based on a developed healthcare infrastructure, a strong Research and Development (R&D) ecosystem, and a strong partnership with the polymer industry, leading to the creation of a broad and expanding array of high-performance polymers. Many of these polymers have properties that are biocompatible and even biodegradable (resins and fibers) for surgical devices, diagnostics, and drug delivery systems. The healthcare industry relies on new product designs and innovative ideas regarding the use of new products developments (e.g., PEEK and other engineering plastics), to ensure successful product introduction that will also meet patients’ preferences for disposable, minimally invasive, and home care solutions. While the Asia Pacific region is leading with the highest CAGR, North America is the second-fastest growing region, due to its regulatory strength (and US regulation innovation), established healthcare system, and leading region with polymer manufacturers serving patients and the medical sector without sacrificing innovation in the development of polymer technologies.
Extensive interviews with experts were conducted to determine and verify the market size for several segments and subsegments and the information gathered through secondary research.
The break-up of interviews with experts is given below:
- By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
- By Designation: C Level: 35%, Director Level: 30%, and Executives: 35%
- By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5%
BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others are some of the key players in the medical polymer market.
The study includes an in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies.
Research Coverage
The market study covers the medical polymer market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on type, application, manufacturing technology, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to enhance their positions in the medical polymer market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical polymer market and its segments and subsegments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the positions of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), challenges (Cost constraints for novel materials, Long term durability and degradation control)
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the medical polymer market
- Market Development: Comprehensive information about lucrative markets – the report analyzes the medical polymer market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical polymer market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others are covered in the medical polymer market.
Table of Contents
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 28
1.3.1 INCLUSIONS AND EXCLUSIONS 29
1.3.2 YEARS CONSIDERED 29
1.4 CURRENCY CONSIDERED 29
1.5 UNITS CONSIDERED 30
1.6 STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 32
2.1.1.1 List of major secondary sources 32
2.1.1.2 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Key data from primary sources 33
2.1.2.2 List of primary interview participants—demand and supply side 34
2.1.2.3 Key industry insights 34
2.1.2.4 Breakdown of primary interviews 34
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 35
2.2.2 TOP-DOWN APPROACH 36
2.3 FORECAST NUMBER CALCULATION 37
2.4 DATA TRIANGULATION 37
2.5 FACTOR ANALYSIS 38
2.6 RESEARCH ASSUMPTIONS 39
2.7 LIMITATIONS AND RISKS 39
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET 45
4.2 MEDICAL POLYMER MARKET, BY TYPE 45
4.3 MEDICAL POLYMER MARKET, BY APPLICATION 46
4.4 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 46
4.5 MEDICAL POLYMER MARKET, BY COUNTRY 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
5.2.1 DRIVERS 49
5.2.1.1 Increasing demand for biocompatible materials 49
5.2.1.2 Surge in global aging population 49
5.2.1.3 Advancements in medical technology 50
5.2.1.4 Rise in chronic diseases 50
5.2.1.5 Regulatory support for medical-grade materials 50
5.2.2 RESTRAINTS 51
5.2.2.1 Regulatory complexities and approvals 51
5.2.2.2 High competition from alternative materials 51
5.2.2.3 Environmental sustainability concerns 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Growth in regenerative medicine 52
5.2.3.2 Demand for minimally invasive devices 53
5.2.3.3 Advancements in biodegradable polymers 53
5.2.4 CHALLENGES 54
5.2.4.1 Cost constraints for novel materials 54
5.2.4.2 Long-term durability and degradation control 55
5.3 PORTER’S FIVE FORCES ANALYSIS 55
5.3.1 THREAT FROM NEW ENTRANTS 56
5.3.2 THREAT OF SUBSTITUTES 57
5.3.3 BARGAINING POWER OF BUYERS 57
5.3.4 BARGAINING POWER OF SUPPLIERS 57
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 58
5.4 MACROECONOMIC INDICATORS 58
5.4.1 GLOBAL GDP TRENDS 58
6 INDUSTRY TRENDS 60
6.1 INTRODUCTION 60
6.2 KEY STAKEHOLDERS & BUYING CRITERIA 60
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 60
6.2.2 BUYING CRITERIA 61
6.3 VALUE CHAIN ANALYSIS 62
6.3.1 RAW MATERIAL SUPPLIERS 63
6.3.2 MANUFACTURERS 64
6.3.3 DISTRIBUTORS 64
6.3.4 END CONSUMERS 64
6.4 ECOSYSTEM ANALYSIS 64
6.5 CASE STUDY ANALYSIS 65
6.5.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS 65
6.5.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY 66
6.6 REGULATORY LANDSCAPE 66
6.7 TECHNOLOGY ANALYSIS 69
6.7.1 KEY TECHNOLOGY 69
6.7.1.1 Biocompatible polymers 69
6.7.1.2 Thermoplastic elastomers 69
6.7.2 COMPLEMENTARY TECHNOLOGY 70
6.7.2.1 Thermoplastic elastomers 70
6.7.2.2 Surface modification techniques 70
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 70
6.9 TRADE ANALYSIS 71
6.9.1 IMPORT SCENARIO 71
6.9.2 EXPORT SCENARIO 73
6.10 KEY CONFERENCES & EVENTS, 2025−2026 74
6.11 PRICING ANALYSIS 75
6.11.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 75
6.11.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022–2024 76
6.11.3 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 76
6.12 INVESTMENT AND FUNDING SCENARIO 78
6.13 PATENT ANALYSIS 78
6.13.1 METHODOLOGY 78
6.13.2 PATENTS GRANTED WORLDWIDE, 2015–2024 79
6.13.3 PUBLICATION TRENDS 79
6.13.4 INSIGHTS 80
6.13.5 LEGAL STATUS OF PATENTS 80
6.13.6 JURISDICTION ANALYSIS 80
6.13.7 TOP APPLICANTS 81
6.14 IMPACT OF AI/GEN AI ON MEDICAL POLYMER MARKET 82
6.15 IMPACT OF 2025 US TARIFF ON MEDICAL POLYMER MARKET 83
6.15.1 INTRODUCTION 83
6.15.2 KEY TARIFF RATES 83
6.15.3 PRICE IMPACT ANALYSIS 84
6.15.4 IMPACT ON KEY COUNTRIES/REGIONS 84
6.15.4.1 North America 84
6.15.4.2 Europe 85
6.15.4.3 Asia Pacific 85
6.15.5 IMPACT ON END-USE INDUSTRIES 85
7 MEDICAL POLYMER MARKET, BY TYPE 86
7.1 INTRODUCTION 87
7.2 MEDICAL PLASTICS 92
7.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET 92
7.2.2 POLYPROPYLENE 92
7.2.3 POLYVINYL CHLORIDE 92
7.2.4 POLYETHYLENE 92
7.2.5 POLYSTYRENE 93
7.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS 93
7.2.6.1 Polyether ether ketone 93
7.2.6.2 Nylon/polyamide 93
7.2.6.3 Polyphenylsulfone 94
7.2.6.4 Polysulfones 94
7.2.6.5 Polymethyl methacrylate 94
7.2.6.6 Polycarbonate 94
7.2.6.7 Acrylonitrile butadiene styrene 94
7.2.6.8 Other Engineering & high-performance plastics 95
7.2.7 OTHER MEDICAL PLASTICS 95
7.3 MEDICAL ELASTOMERS 95
7.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET 95
7.3.2 SILICONE 95
7.3.3 THERMOPLASTIC ELASTOMERS 96
7.3.3.1 Thermoplastic polyurethane 96
7.3.3.2 Thermoplastic vulcanizates 96
7.3.3.3 Thermoplastic styrenic elastomers 96
7.3.3.3.1 Poly(styrene-butadiene-styrene) 97
7.3.3.3.2 Styrene-ethylene-butylene-styrene 97
7.3.3.4 Thermoplastic copolyester elastomers 97
7.4 OTHER MEDICAL ELASTOMERS 97
8 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY 98
8.1 INTRODUCTION 99
8.2 EXTRUSION TUBING 101
8.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS,
AND SURGICAL INSTRUMENTS TO DRIVE MARKET 101
8.3 COMPRESSION MOLDING 101
8.3.1 INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET 101
8.4 INJECTION MOLDING 101
8.4.1 INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET 101
8.5 OTHER MANUFACTURING TECHNOLOGIES 102
9 MEDICAL POLYMER MARKET, BY APPLICATION 103
9.1 INTRODUCTION 104
9.2 MEDICAL DISPOSABLES 109
9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET 109
9.2.2 GLOVES 109
9.2.3 SYRINGES 109
9.2.4 MEDICAL BAGS 110
9.2.5 OTHER MEDICAL DISPOSABLES 110
9.3 MEDICAL INSTRUMENTS & DEVICES 111
9.3.1 INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET 111
9.3.2 MEDICAL TUBES 111
9.3.3 CATHETERS 111
9.3.4 DRUG DELIVERY INSTRUMENTS 112
9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES 112
9.4 PROSTHETICS 113
9.4.1 RISING DEMAND FOR ADVANCED LIMB PROSTHESES AND IMPLANTS TO DRIVE MARKET 113
9.4.2 IMPLANTS 113
9.4.3 LIMB PROSTHESIS 113
9.4.4 OTHER PROSTHETICS APPLICATIONS 114
9.5 DIAGNOSTIC INSTRUMENTS & TOOLS 114
9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET 114
9.5.2 DENTAL TOOLS 114
9.5.3 SURGICAL INSTRUMENTS 115
9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS 115
9.6 OTHER APPLICATIONS 116
10 MEDICAL POLYMER MARKET, BY REGION 117
10.1 INTRODUCTION 118
10.2 NORTH AMERICA 120
10.2.1 US 131
10.2.1.1 High R&D investments in medical sector to drive market 131
10.2.2 CANADA 139
10.2.2.1 Emerging demand for dental implants to drive market 139
10.2.3 MEXICO 148
10.2.3.1 Expansion of manufacturing facilities to drive market 148
10.3 ASIA PACIFIC 156
10.3.1 CHINA 168
10.3.1.1 Establishment of medical device manufacturing units and investment in other healthcare-related sectors to drive market 168
10.3.2 INDIA 176
10.3.2.1 Rapid economic growth and growing population to drive market 176
10.3.3 SOUTH KOREA 185
10.3.3.1 Advanced healthcare and medical technologies to boost market 185
10.3.4 JAPAN 193
10.3.4.1 Developments in minimally invasive treatment and robotic surgery to support market growth 193
10.3.5 AUSTRALIA 201
10.3.5.1 Regulatory compliance and strategic collaborations to support market growth 201
10.3.6 REST OF ASIA PACIFIC 209
10.4 MIDDLE EAST & AFRICA 217
10.4.1 GCC COUNTRIES 228
10.4.1.1 Saudi Arabia 229
10.4.1.1.1 Surge in aging population to drive demand for medical polymers 229
10.4.1.2 UAE 237
10.4.1.2.1 Population growth and changing epidemiology to drive market 237
10.4.1.3 Rest of GCC 245
10.4.2 SOUTH AFRICA 253
10.4.2.1 Increased government spending on healthcare to drive market 253
10.4.3 REST OF MIDDLE EAST & AFRICA 261
10.5 EUROPE 270
10.5.1 GERMANY 281
10.5.1.1 Rising demand in dental implant application to drive market 281
10.5.2 FRANCE 289
10.5.2.1 Aging population and sedentary lifestyle to boost demand for polymers 289
10.5.3 UK 297
10.5.3.1 Growing incidences of chronic diseases and government support for innovation to drive market 297
10.5.4 ITALY 305
10.5.4.1 Strong production facilities with presence of global players to propel market growth 305
10.5.5 SPAIN 313
10.5.5.1 Surge in government funding for healthcare sector to support market 313
10.5.6 REST OF EUROPE 321
10.6 SOUTH AMERICA 329
10.6.1 BRAZIL 340
10.6.1.1 Growing aging population, expanding economy, and increasing health awareness to drive market 340
10.6.2 ARGENTINA 348
10.6.2.1 Availability of highly trained specialists and low cost of medical services boosting medical tourism industry 348
10.6.3 REST OF SOUTH AMERICA 356
11 COMPETITIVE LANDSCAPE 365
11.1 OVERVIEW 365
11.2 KEY PLAYER STRATEGIES 365
11.3 REVENUE ANALYSIS, 2022–2024 368
11.4 MARKET SHARE ANALYSIS, 2024 368
11.5 COMPANY VALUATION AND FINANCIAL METRICS 371
11.6 BRAND/PRODUCT COMPARISON ANALYSIS 372
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 373
11.7.1 STARS 373
11.7.2 EMERGING LEADERS 373
11.7.3 PERVASIVE PLAYERS 373
11.7.4 PARTICIPANTS 373
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 375
11.7.5.1 Company footprint 375
11.7.5.2 Region footprint 376
11.7.5.3 Type footprint 377
11.7.5.4 Application footprint 378
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 379
11.8.1 PROGRESSIVE COMPANIES 379
11.8.2 RESPONSIVE COMPANIES 379
11.8.3 DYNAMIC COMPANIES 379
11.8.4 STARTING BLOCKS 379
11.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024 381
11.8.5.1 Detailed list of key startups/SMEs 381
11.8.5.2 Competitive benchmarking of key startups/SMEs 382
11.9 COMPETITIVE SCENARIO 383
11.9.1 PRODUCT LAUNCHES 383
11.9.2 DEALS 384
11.9.3 EXPANSIONS 386
12 COMPANY PROFILES 390
12.1 MAJOR PLAYERS 390
12.1.1 BASF 390
12.1.1.1 Business overview 390
12.1.1.2 Products/Services/Solutions offered 391
12.1.1.3 Recent developments 392
12.1.1.3.1 Product launches 392
12.1.1.3.2 Deals 393
12.1.1.4 MnM view 393
12.1.1.4.1 Key strengths 393
12.1.1.4.2 Strategic choices 393
12.1.1.4.3 Weaknesses and competitive threats 394
12.1.2 SABIC 395
12.1.2.1 Business overview 395
12.1.2.2 Products/Services/Solutions offered 396
12.1.2.3 Recent developments 397
12.1.2.3.1 Deals 397
12.1.2.4 MnM view 398
12.1.2.4.1 Key strengths 398
12.1.2.4.2 Strategic choices 398
12.1.2.4.3 Weaknesses and competitive threats 398
12.1.3 COVESTRO AG 399
12.1.3.1 Business overview 399
12.1.3.2 Products/Services/Solutions offered 400
12.1.3.3 Recent developments 401
12.1.3.3.1 Product launches 401
12.1.3.3.2 Expansions 401
12.1.3.4 MnM view 402
12.1.3.4.1 Key strengths 402
12.1.3.4.2 Strategic choices 403
12.1.3.4.3 Weaknesses and competitive threats 403
12.1.4 CELANESE CORPORATION 404
12.1.4.1 Business overview 404
12.1.4.2 Products/Services/Solutions offered 405
12.1.4.3 Recent developments 406
12.1.4.3.1 Deals 406
12.1.4.3.2 Expansions 407
12.1.4.4 MnM view 407
12.1.4.4.1 Key strengths 407
12.1.4.4.2 Strategic choices 408
12.1.4.4.3 Weaknesses and competitive threats 408
12.1.5 EVONIK INDUSTRIES 409
12.1.5.1 Business overview 409
12.1.5.2 Products/Services/Solutions offered 410
12.1.5.3 Recent developments 411
12.1.5.3.1 Product launches 411
12.1.5.3.2 Expansions 412
12.1.5.4 MnM view 413
12.1.5.4.1 Key strengths 413
12.1.5.4.2 Strategic choices 413
12.1.5.4.3 Weaknesses and competitive threats 413
12.1.6 ARKEMA 414
12.1.6.1 Business overview 414
12.1.6.2 Products/Services/Solutions offered 415
12.1.6.3 Recent developments 416
12.1.6.3.1 Product launches 416
12.1.6.3.2 Deals 416
12.1.6.3.3 Expansions 417
12.1.6.4 MnM view 417
12.1.6.4.1 Key strengths 417
12.1.7 SOLVAY 419
12.1.7.1 Business overview 419
12.1.7.2 Products/Services/Solutions offered 421
12.1.7.3 MnM view 421
12.1.7.3.1 Key strengths 421
12.1.8 KURARAY CO., LTD. 422
12.1.8.1 Business overview 422
12.1.8.2 Products/Services/Solutions offered 423
12.1.8.3 Recent developments 424
12.1.8.3.1 Expansions 424
12.1.8.4 MnM view 424
12.1.9 MOMENTIVE PERFORMANCE MATERIALS INC. 425
12.1.9.1 Business overview 425
12.1.9.2 Products/Services/Solutions offered 425
12.1.9.3 Recent developments 426
12.1.9.3.1 Deals 426
12.1.9.3.2 Expansions 426
12.1.9.4 MnM view 427
12.1.10 DUPONT 428
12.1.10.1 Business overview 428
12.1.10.2 Products/Services/Solutions offered 429
12.1.10.3 Recent developments 429
12.1.10.3.1 Deals 429
12.1.10.3.2 Expansions 429
12.1.10.4 MnM view 430
12.2 OTHER PLAYERS 431
12.2.1 TRINSEO 431
12.2.2 KRATON CORPORATION 432
12.2.3 TOTAL PLASTICS 433
12.2.4 SIMONA AMERICA 434
12.2.5 DSM 435
12.2.6 INVIBIO 436
12.2.7 AVIENT CORPORATION 436
12.2.8 RTP COMPANY 437
12.2.9 TEKNIPLEX 438
12.2.10 TEKNOR APEX 439
12.2.11 MITSUBISHI CHEMICALS ADVANCED MATERIALS 440
12.2.12 WACKER CHIMIE 440
12.2.13 HARDIE POLYMERS 441
12.2.14 ELIX POLYMERS 442
12.2.15 INNOVATIVE POLYMER COMPOUNDS 443
13 APPENDIX 444
13.1 DISCUSSION GUIDE 444
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 447
13.3 CUSTOMIZATION OPTIONS 449
13.4 RELATED REPORTS 449
13.5 AUTHOR DETAILS 450
LIST OF TABLES
TABLE 1 MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS 29
TABLE 2 MEDICAL POLYMER MARKET: PORTER’S FIVE FORCES ANALYSIS 55
TABLE 3 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018–2025 59
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS 61
TABLE 5 KEY BUYING CRITERIA IN MAJOR APPLICATIONS 62
TABLE 6 MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM 65
TABLE 7 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 11 MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2025−2026 74
TABLE 12 AVERAGE SELLING PRICE OF MEDICAL POLYMER, BY REGION,
2022–2024 (USD/KG) 75
TABLE 13 AVERAGE SELLING PRICE OF MEDICAL POLYMER OFFERED BY KEY PLAYERS,
BY APPLICATION, 2024 (USD/KG) 77
TABLE 14 TOP 10 PATENT OWNERS, 2015–2024 82
TABLE 15 TABLE 1: US-ADJUSTED RECIPROCAL TARIFF RATES 83
TABLE 16 MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 88
TABLE 17 MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 89
TABLE 18 MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 90
TABLE 19 MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 91
TABLE 20 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2022–2024 (USD MILLION) 99
TABLE 21 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2025–2030 (USD MILLION) 100
TABLE 22 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2022–2024 (KILOTON) 100
TABLE 23 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2025–2030 (KILOTON) 100
TABLE 24 MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 105
TABLE 25 MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 106
TABLE 26 MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 107
TABLE 27 MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 108
TABLE 28 MEDICAL POLYMER MARKET, BY REGION, 2022–2024 (USD MILLION) 118
TABLE 29 MEDICAL POLYMER MARKET, BY REGION, 2025–2030 (USD MILLION) 119
TABLE 30 MEDICAL POLYMER MARKET, BY REGION, 2022–2024 (KILOTON) 119
TABLE 31 MEDICAL POLYMER MARKET, BY REGION, 2025–2030 (KILOTON) 119
TABLE 32 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 121
TABLE 33 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 121
TABLE 34 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2022–2024 (KILOTON) 121
TABLE 35 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2025–2030 (KILOTON) 121
TABLE 36 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 122
TABLE 37 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 123
TABLE 38 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 124
TABLE 39 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 125
TABLE 40 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 126
TABLE 41 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 127
TABLE 42 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 128
TABLE 43 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 129
TABLE 44 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 129
TABLE 45 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 130
TABLE 46 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 130
TABLE 47 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 130
TABLE 48 US: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 132
TABLE 49 US: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 133
TABLE 50 US: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 134
TABLE 51 US: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 135
TABLE 52 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 136
TABLE 53 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 137
TABLE 54 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 138
TABLE 55 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 139
TABLE 56 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 141
TABLE 57 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 142
TABLE 58 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 143
TABLE 59 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 144
TABLE 60 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 145
TABLE 61 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 146
TABLE 62 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 147
TABLE 63 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 148
TABLE 64 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 149
TABLE 65 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 150
TABLE 66 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 151
TABLE 67 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 152
TABLE 68 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 153
TABLE 69 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 154
TABLE 70 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 155
TABLE 71 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 156
TABLE 72 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 157
TABLE 73 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 158
TABLE 74 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON) 158
TABLE 75 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON) 158
TABLE 76 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 159
TABLE 77 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 160
TABLE 78 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 161
TABLE 79 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 162
TABLE 80 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 163
TABLE 81 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 164
TABLE 82 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 165
TABLE 83 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 166
TABLE 84 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 166
TABLE 85 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 167
TABLE 86 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 167
TABLE 87 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 167
TABLE 88 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 169
TABLE 89 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 170
TABLE 90 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 171
TABLE 91 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 172
TABLE 92 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 173
TABLE 93 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 174
TABLE 94 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 175
TABLE 95 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 176
TABLE 96 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 177
TABLE 97 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 178
TABLE 98 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 179
TABLE 99 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 180
TABLE 100 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 181
TABLE 101 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 182
TABLE 102 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 183
TABLE 103 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 184
TABLE 104 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 186
TABLE 105 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 187
TABLE 106 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 188
TABLE 107 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 189
TABLE 108 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 190
TABLE 109 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 191
TABLE 110 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 192
TABLE 111 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 193
TABLE 112 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 194
TABLE 113 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 195
TABLE 114 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 196
TABLE 115 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 197
TABLE 116 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 198
TABLE 117 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 199
TABLE 118 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 200
TABLE 119 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 201
TABLE 120 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 202
TABLE 121 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 203
TABLE 122 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 204
TABLE 123 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 205
TABLE 124 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 206
TABLE 125 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 207
TABLE 126 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 208
TABLE 127 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 209
TABLE 128 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 210
TABLE 129 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 211
TABLE 130 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (KILOTON) 212
TABLE 131 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (KILOTON) 213
TABLE 132 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 214
TABLE 133 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 215
TABLE 134 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 216
TABLE 135 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 217
TABLE 136 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 218
TABLE 137 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 218
TABLE 138 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2022–2024 (KILOTON) 219
TABLE 139 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2025–2030 (KILOTON) 219
TABLE 140 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 220
TABLE 141 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 221
TABLE 142 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (KILOTON) 222
TABLE 143 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (KILOTON) 223
TABLE 144 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 224
TABLE 145 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 225
TABLE 146 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 226
TABLE 147 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 227
TABLE 148 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 227
TABLE 149 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 228
TABLE 150 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 228
TABLE 151 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 228
TABLE 152 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 230
TABLE 153 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 231
TABLE 154 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 232
TABLE 155 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 233
TABLE 156 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 234
TABLE 157 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 235
TABLE 158 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 236
TABLE 159 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 237
TABLE 160 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 238
TABLE 161 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 239
TABLE 162 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 240
TABLE 163 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 241
TABLE 164 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 242
TABLE 165 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 243
TABLE 166 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 244
TABLE 167 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 245
TABLE 168 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 246
TABLE 169 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 247
TABLE 170 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 248
TABLE 171 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 249
TABLE 172 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 250
TABLE 173 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 251
TABLE 174 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 252
TABLE 175 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 253
TABLE 176 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 254
TABLE 177 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 255
TABLE 178 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 256
TABLE 179 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 257
TABLE 180 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 258
TABLE 181 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 259
TABLE 182 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 260
TABLE 183 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 261
TABLE 184 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 262
TABLE 185 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 263
TABLE 186 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (KILOTON) 264
TABLE 187 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (KILOTON) 265
TABLE 188 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET,
BY APPLICATION, 2022–2024 (USD MILLION) 266
TABLE 189 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 267
TABLE 190 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 268
TABLE 191 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET,
BY APPLICATION, 2025–2030 (KILOTON) 269
TABLE 192 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 271
TABLE 193 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 271
TABLE 194 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON) 271
TABLE 195 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON) 272
TABLE 196 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 272
TABLE 197 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 273
TABLE 198 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 274
TABLE 199 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 275
TABLE 200 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 276
TABLE 201 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 277
TABLE 202 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 278
TABLE 203 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 279
TABLE 204 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2022–2024 (USD MILLION) 279
TABLE 205 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2025–2030 (USD MILLION) 280
TABLE 206 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2022–2024 (KILOTON) 280
TABLE 207 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY,
2025–2030 (KILOTON) 280
TABLE 208 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 282
TABLE 209 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 283
TABLE 210 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 284
TABLE 211 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 285
TABLE 212 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 286
TABLE 213 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 287
TABLE 214 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 288
TABLE 215 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 289
TABLE 216 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 290
TABLE 217 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 291
TABLE 218 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 292
TABLE 219 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 293
TABLE 220 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 294
TABLE 221 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 295
TABLE 222 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 296
TABLE 223 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 297
TABLE 224 UK: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 298
TABLE 225 UK: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 299
TABLE 226 UK: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 300
TABLE 227 UK: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 301
TABLE 228 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 302
TABLE 229 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 303
TABLE 230 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 304
TABLE 231 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 305
TABLE 232 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 306
TABLE 233 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 307
TABLE 234 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 308
TABLE 235 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 309
TABLE 236 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 310
TABLE 237 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 311
TABLE 238 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 312
TABLE 239 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 313
TABLE 240 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 314
TABLE 241 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 315
TABLE 242 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 316
TABLE 243 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 317
TABLE 244 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 318
TABLE 245 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 319
TABLE 246 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 320
TABLE 247 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 321
TABLE 248 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 322
TABLE 249 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 323
TABLE 250 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 324
TABLE 251 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 325
TABLE 252 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 326
TABLE 253 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 327
TABLE 254 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 328
TABLE 255 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 329
TABLE 256 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2022–2024 (USD MILLION) 330
TABLE 257 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 330
TABLE 258 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2022–2024 (KILOTON) 330
TABLE 259 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY,
2025–2030 (KILOTON) 330
TABLE 260 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 331
TABLE 261 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 332
TABLE 262 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 333
TABLE 263 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 334
TABLE 264 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 335
TABLE 265 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 336
TABLE 266 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 337
TABLE 267 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 338
TABLE 268 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION) 338
TABLE 269 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION) 339
TABLE 270 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON) 339
TABLE 271 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON) 339
TABLE 272 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 341
TABLE 273 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 342
TABLE 274 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 343
TABLE 275 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 344
TABLE 276 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 345
TABLE 277 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 346
TABLE 278 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON) 347
TABLE 279 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON) 348
TABLE 280 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION) 349
TABLE 281 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION) 350
TABLE 282 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON) 351
TABLE 283 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON) 352
TABLE 284 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 353
TABLE 285 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 354
TABLE 286 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 355
TABLE 287 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 356
TABLE 288 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (USD MILLION) 357
TABLE 289 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (USD MILLION) 358
TABLE 290 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2022–2024 (KILOTON) 359
TABLE 291 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE,
2025–2030 (KILOTON) 360
TABLE 292 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (USD MILLION) 361
TABLE 293 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 362
TABLE 294 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2022–2024 (KILOTON) 363
TABLE 295 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION,
2025–2030 (KILOTON) 364
TABLE 296 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2025 365
TABLE 297 MEDICAL POLYMER MARKET: DEGREE OF COMPETITION 369
TABLE 298 MEDICAL POLYMER MARKET: REGION FOOTPRINT 376
TABLE 299 MEDICAL POLYMER MARKET: TYPE FOOTPRINT 377
TABLE 300 MEDICAL POLYMER MARKET: APPLICATION FOOTPRINT 378
TABLE 301 MEDICAL POLYMER MARKET: KEY STARTUPS/SMES 381
TABLE 302 MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 382
TABLE 303 MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 383
TABLE 304 MEDICAL POLYMER MARKET: DEALS, JANUARY 2021–JULY 2025 384
TABLE 305 MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021–JULY 2025 386
TABLE 306 BASF: COMPANY OVERVIEW 390
TABLE 307 BASF: PRODUCTS/SERVICES/SOLUTIONS OFFERED 391
TABLE 308 BASF: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 392
TABLE 309 BASF: DEALS, JANUARY 2021–JULY 2025 393
TABLE 310 SABIC: COMPANY OVERVIEW 395
TABLE 311 SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 396
TABLE 312 SABIC: DEALS, JANUARY 2021–JULY 2025 397
TABLE 313 COVESTRO AG: COMPANY OVERVIEW 399
TABLE 314 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 400
TABLE 315 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 401
TABLE 316 COVESTRO AG: EXPANSIONS, JANUARY 2021–JULY 2025 401
TABLE 317 CELANESE CORPORATION: COMPANY OVERVIEW 404
TABLE 318 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 405
TABLE 319 CELANESE CORPORATION: DEALS, JANUARY 2021–JULY 2025 406
TABLE 320 CELANESE CORPORATION: EXPANSIONS, JANUARY 2021–JULY 2025 407
TABLE 321 EVONIK INDUSTRIES: COMPANY OVERVIEW 409
TABLE 322 EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 410
TABLE 323 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 411
TABLE 324 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021–JULY 2025 412
TABLE 325 ARKEMA: COMPANY OVERVIEW 414
TABLE 326 ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 415
TABLE 327 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 416
TABLE 328 ARKEMA: DEALS, JANUARY 2021–JULY 2025 416
TABLE 329 ARKEMA: EXPANSIONS, JANUARY 2021–JULY 2025 417
TABLE 330 SOLVAY: COMPANY OVERVIEW 419
TABLE 331 SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 421
TABLE 332 KURARAY CO., LTD.: COMPANY OVERVIEW 422
TABLE 333 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 423
TABLE 334 KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021–JULY 2025 424
TABLE 335 MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW 425
TABLE 336 MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 425
TABLE 337 MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021–JULY 2025 426
TABLE 338 MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS,
JANUARY 2021–JULY 2025 426
TABLE 339 DUPONT: COMPANY OVERVIEW 428
TABLE 340 DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 429
TABLE 341 DUPONT: DEALS, JANUARY 2021–JULY 2025 429
TABLE 342 DUPONT: EXPANSIONS, JANUARY 2021–JULY 2025 429
TABLE 343 TRINSEO: COMPANY OVERVIEW 431
TABLE 344 KRATON CORPORATION: COMPANY OVERVIEW 432
TABLE 345 TOTAL PLASTICS: COMPANY OVERVIEW 433
TABLE 346 SIMONA AMERICA: COMPANY OVERVIEW 434
TABLE 347 DSM: COMPANY OVERVIEW 435
TABLE 348 INVIBIO: COMPANY OVERVIEW 436
TABLE 349 AVIENT CORPORATION: COMPANY OVERVIEW 436
TABLE 350 RTP COMPANY: COMPANY OVERVIEW 437
TABLE 351 TEKNIPLEX: COMPANY OVERVIEW 438
TABLE 352 TEKNOR APEX: COMPANY OVERVIEW 439
TABLE 353 MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW 440
TABLE 354 WACKER CHIMIE: COMPANY OVERVIEW 440
TABLE 355 HARDIE POLYMERS: COMPANY OVERVIEW 441
TABLE 356 ELIX POLYMERS: COMPANY OVERVIEW 442
TABLE 357 INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW 443
LIST OF FIGURES
FIGURE 1 MEDICAL POLYMER MARKET SEGMENTATION AND REGIONAL SCOPE 28
FIGURE 2 MEDICAL POLYMER MARKET: RESEARCH DESIGN 31
FIGURE 3 MEDICAL POLYMER MARKET: BOTTOM-UP APPROACH 35
FIGURE 4 MEDICAL POLYMER MARKET: TOP-DOWN APPROACH 36
FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL POLYMER MARKET TOP-DOWN APPROACH 36
FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS 37
FIGURE 7 MEDICAL POLYMER MARKET: DATA TRIANGULATION 38
FIGURE 8 MEDICAL PLASTICS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 42
FIGURE 9 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD 43
FIGURE 10 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 43
FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 44
FIGURE 12 INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD 45
FIGURE 13 MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD 45
FIGURE 14 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 46
FIGURE 15 EXTRUSION TUBING SEGMENT TO HOLD LARGEST SHARE DURING FORECAST PERIOD 46
FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 47
FIGURE 17 MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 48
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET 56
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS 60
FIGURE 20 KEY BUYING CRITERIA IN MAJOR APPLICATIONS 61
FIGURE 21 MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 22 MEDICAL POLYMER ECOSYSTEM 64
FIGURE 23 MEDICAL POLYMER MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 71
FIGURE 24 IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020–2024 (USD MILLION) 72
FIGURE 25 EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020–2024 (USD MILLION) 73
FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 75
FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022–2024 76
FIGURE 28 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 77
FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2019−2023 (USD MILLION) 78
FIGURE 32 LEGAL STATUS OF PATENTS, 2015–2024 80
FIGURE 35 MEDICAL PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 87
FIGURE 36 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 99
FIGURE 37 MEDICAL INSTRUMENTS & DEVICES TO HOLD LARGEST SHARE DURING FORECAST PERIOD 104
FIGURE 38 MEDICAL POLYMER MARKET SNAPSHOT 118
FIGURE 39 NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT 120
FIGURE 40 ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT 157
FIGURE 41 EUROPE: MEDICAL POLYMER MARKET SNAPSHOT 270
FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET,
2022–2024 368
FIGURE 43 SHARES OF TOP FIVE COMPANIES IN MEDICAL POLYMER MARKET, 2024 369
FIGURE 44 VALUATION OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024 371
FIGURE 45 FINANCIAL METRICS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024 372
FIGURE 46 MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON 372
FIGURE 47 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 374
FIGURE 48 MEDICAL POLYMER MARKET: COMPANY FOOTPRINT 375
FIGURE 49 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 380
FIGURE 50 BASF: COMPANY SNAPSHOT 391
FIGURE 51 SABIC: COMPANY SNAPSHOT 396
FIGURE 52 COVESTRO AG: COMPANY SNAPSHOT 400
FIGURE 53 CELANESE CORPORATION: COMPANY SNAPSHOT 405
FIGURE 54 EVONIK INDUSTRIES: COMPANY SNAPSHOT 410
FIGURE 55 ARKEMA: COMPANY SNAPSHOT 415
FIGURE 56 SOLVAY: COMPANY SNAPSHOT 420
FIGURE 57 KURARAY CO., LTD.: COMPANY SNAPSHOT 423
FIGURE 58 DUPONT: COMPANY SNAPSHOT 428
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31
- 高純度ガス市場規模、シェア、動向、2030年までの世界予測 2025-10-30
- 動物用生物学的製剤市場規模、シェア、動向、2030年までの世界予測 2025-10-30
- エンジニアリング樹脂向け難燃剤市場規模、シェア、動向、2030年までの世界予測 2025-10-29
- アプリケーションモダナイゼーションサービス市場規模、シェア、動向、2031年までの世界予測 2025-10-29